drugset / Trial / NCT03532880
A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety of a new medication, Olaparib, combined with radiation therapy for participants with small cell lung cancer.
Timeline
- Start
- 2018-07-12
- Primary completion
- 2025-02-04
- Completion
- 2025-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olaparib | Small molecule | 50 mg | Oral |
| Subject | Olaparib | Small molecule | 100 mg | Oral |
| Subject | Olaparib | Small molecule | 150 mg | Oral |
| Subject | Olaparib | Small molecule | 200 mg | Oral |
| Subject | Olaparib | Small molecule | 250 mg | Oral |
| Subject | Olaparib | Small molecule | 300 mg | Oral |